E.I. Eboulet

611 citations

15 papers · 171 indexed · h-index 9

Impact in

Pulmonary and Respiratory Medicine
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Occupational and environmental lung diseases
Oncology
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in ⓘ

Pulmonary and Respiratory Medicine 13
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 2
- Occupational and environmental lung diseases 2
- Pleural and Pulmonary Diseases 2
Oncology 5
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Miklos Pless (11 shared papers)Michael Mark (7 shared papers)Solange Peters (6 shared papers)Diem Vuong (4 shared papers)Matthias Gückenberger (4 shared papers)Stephanie Tanadini‐Lang (4 shared papers)Patrizia Froesch (5 shared papers)Sandra Thierstein (4 shared papers)
Journals: Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Journal of Thoracic and Cardiovascular Surgery (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Scientific Reports (1 paper)
Partner nations: Switzerland Germany Italy

In The Last Decade

E.I. Eboulet

14 papers receiving 170 citations

Peers

Countries citing papers authored by E.I. Eboulet

Since Specialization

Citations

This map shows the geographic impact of E.I. Eboulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.I. Eboulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.I. Eboulet more than expected).

Fields of papers citing papers by E.I. Eboulet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.I. Eboulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.I. Eboulet. The network helps show where E.I. Eboulet may publish in the future.

Co-authors

The 25 scholars most cited alongside E.I. Eboulet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.I. Eboulet Line = papers co-authored together E.I. Eboulet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12) International Journal of Radiation OncologyBiologyPhysics ·Hansjörg Vees, Francesca Caparrotti, E.I. Eboulet, Alexandros Xyrafas, Andrea Fuhrer, Urs R. Meier, Michael Mark, Olgun Eliçin, Daniel M. Aebersold, Daniel R. Zwahlen, Tobias Finazzi, Abdelkarim S. Allal, Paul Martin Putora, Francesco Martucci, Christine Biaggi Rudolf, Karin Ribi	2020	25
2	SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial. Journal of Clinical Oncology ·Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet, Spasenija Savic, Daniel Betticher, Adrienne Bettini, M. Frueh, Markus Joerger, Christian Britschgi, Solange Peters, Michael Mark, Adrian F. Ochsenbein, Wolf Dieter Janthur, Christine Waibel, Nicolas Mach, Michel González, Patrizia Froesch, Gilles Godar, Corinne Rusterholz, Miklos Pless	2020	24
3	Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types British Journal of Radiology ·S. Denzler, Diem Vuong, Marta Bogowicz, Matea Pavic, Thomas Frauenfelder, Sandra Thierstein, E.I. Eboulet, Britta Maurer, Janine Gote-Schniering, Hubert S. Gabryś, I. Schmitt-Opitz, Miklos Pless, Robert Foerster, Matthias Gückenberger, Stephanie Tanadini‐Lang	2021	23
4	Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16) Annals of Oncology ·Yannis Metaxas, Martin Früh, E.I. Eboulet, Federica Grosso, Miklos Pless, Paolo Andrea Zucali, Giovanni Luca Ceresoli, Michael Mark, Martina Schneider, Antonio Maconi, Matteo Perrino, Christine Biaggi‐Rudolf, Patrizia Froesch, Sabine Schmid, Christine Waibel, Christina Appenzeller, Daniel Rauch, Roger von Moos	2020	22
5	Radiomics Feature Activation Maps as a New Tool for Signature Interpretability Frontiers in Oncology ·Diem Vuong, Stephanie Tanadini‐Lang, Ze Wu, Robert J. Marks, Jan Unkelbach, Sven Hillinger, E.I. Eboulet, Sandra Thierstein, Solange Peters, Miklos Pless, Matthias Gückenberger, Marta Bogowicz	2020	19
6	Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging EJNMMI Research ·Carol Oliveira, Florian Amstutz, Diem Vuong, Marta Bogowicz, Martin Hüllner, Robert Foerster, Lucas Basler, Christina Schröder, E.I. Eboulet, Miklos Pless, Sandra Thierstein, Solange Peters, Sven Hillinger, Stephanie Tanadini‐Lang, Matthias Gückenberger	2021	12
7	1237MO SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC) – A multicenter single-arm phase II trial Annals of Oncology ·Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet, S. Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Christian Britschgi, Solange Peters, Michael Mark, Adrian F. Ochsenbein, W-D. Janthur, Christine Waibel, Nicolas Mach, Michel González, Patrizia Froesch, Gilles Godar, Corinne Rusterholz, Miklos Pless	2020	11
8	SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2 Cancer Immunology Immunotherapy ·Michael Mark, Patrizia Froesch, E.I. Eboulet, Alfredo Addeo, Miklos Pless, Sacha I. Rothschild, Wolf-Dieter Janthur, Henning Burmeister, Alex Friedlaender, Martina Schneider, Yannis Metaxas, Markus Joerger, Luciano Wannesson, Michael Schwitter, Nathalie Baudoux, Susanne Weindler, Christine Biaggi‐Rudolf, Martin Früh	2020	11
9	Extended resection for potentially operable patients with stage III non–small cell lung cancer after induction treatment Journal of Thoracic and Cardiovascular Surgery ·Katarzyna Furrer, Walter Weder, E.I. Eboulet, Daniel Betticher, Miklos Pless, Roger Stupp, Thorsten Krueger, Jean Yannis Perentes, Ralph A. Schmid, Didier Lardinois, Markus Furrer, Martin Früh, Solange Peters, Alessandra Curioni‐Fontecedro, Rolf A. Stahel, Sacha I. Rothschild, Stefanie Hayoz, Isabelle Opitz	2022	8
10	Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC Scientific Reports ·Diem Vuong, Marta Bogowicz, Leonard Wee, Oliver Riesterer, Eugenia Vlaskou Badra, Louisa Abigail D’Cruz, Panagiotis Balermpas, Janita E. van Timmeren, Simon Burgermeister, André Dekker, Dirk De Ruysscher, Jan Unkelbach, Sandra Thierstein, E.I. Eboulet, Solange Peters, Miklos Pless, Matthias Gückenberger, Stephanie Tanadini‐Lang	2021	5
11	Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. Journal of Clinical Oncology ·Alfredo Addeo, Markus Joerger, Sacha I. Rothschild, E.I. Eboulet, Gilles Godar, Christine Waibel-Pachinger, Simon Haefliger, Michael Mark, Eugenio Fernández, Nicolas Mach, Laetitia Mauti, M. Frueh	2021	4
12	MA09.02 SAKK 16/14 - T-Cell Receptor Repertoire Metrics Predict Response to Neoadjuvant Durvalumab in Patients With Stage IIIA(N2) NSCLC Journal of Thoracic Oncology ·Ilaria Alborelli, Katharina Leonards, Michele Manzo, E. Keller, Petra Herzig, Marta Trüb, Dagmar Schmid, E.I. Eboulet, Gilles Godar, Miklos Pless, Alfred Zippelius, Philip Jermann, S. Savic Prince, Sacha I. Rothschild	2021	3
13	Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial European Journal of Cancer ·Cédric Panje, Stefanie Hayoz, Wolfgang Eisterer, Viviane Hess, Peter Thuss‐Patience, Sabina Schacher, Donat Dürr, Dorothea Wagner, Michael Girschikofsky, E.I. Eboulet, M. Stahl, Thomas Ruhstaller	2022	2
14	SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial Annals of Oncology ·Yannis Metaxas, M. Frueh, E.I. Eboulet, Federica Grosso, Miklos Pless, Paolo Andrea Zucali, Giovanni Luca Ceresoli, Michael Mark, Martina Schneider, Annalisa Roveta, Matteo Perrino, C. Biaggi Rudolf, Patrizia Froesch, Schuyler Schmidt, Christine Waibel, Christina Appenzeller, Daniel Rauch, Roger von Moos	2019	2
15	Application de la régression quantile et ses tests statistiques sur les données PISA en Suisse romande E.I. Eboulet, Alina Matei	2013	0

About E.I. Eboulet

E.I. Eboulet is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Hepatology, having authored 15 papers that have together received 171 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (2 papers), Gastric Cancer Management and Outcomes (2 papers), Occupational and environmental lung diseases (2 papers) and Pleural and Pulmonary Diseases (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (125 citations), Oncology (76 citations), Radiology, Nuclear Medicine and Imaging (59 citations), Health Informatics (3 citations) and Genetics (15 citations). E.I. Eboulet has collaborated with scholars based in Switzerland, Germany and Italy. Frequent co-authors include Miklos Pless, Michael Mark, Solange Peters, Diem Vuong, Matthias Gückenberger, Stephanie Tanadini‐Lang, Patrizia Froesch, Sandra Thierstein, Marta Bogowicz and Markus Joerger. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic and Cardiovascular Surgery, International Journal of Radiation Oncology*Biology*Physics and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact